Brainlab AG

Brainlab AG

Stefan Vilsmeier founded Brainlab AG in Munich in 1989, initially developing a surgical planning system that became the company's core platform. Vilsmeier, now CEO alongside CFO Martin Vetter, owns 100% of the company and has taken no external funding — a rarity among medtech firms of its scale (per Forbes, 2020). Brainlab operates in three primary segments: surgical navigation (image-guided systems for neurosurgery, spine, ENT and craniomaxillofacial procedures), radiotherapy (planning and positioning software for cancer treatment), and digital surgery (augmented reality, data analytics, and wearables such as the Loop-X mobile imaging robot). The company's Loop-X device, launched in 2019, competes directly with Medtronic's StealthStation and Stryker's navigation platforms. Geographic coverage extends across Europe, the Americas, Asia, and the Middle East, with a network of regional offices and certified service partners. The firm employs roughly 2,000 people worldwide and maintains a wholly-owned operating structure without a family office or external investment arm. Brainlab operates the Vilsmeier family's single philanthropic entity through a foundation that focuses on pediatric neurosurgery access in low-income countries (per Brainlab official communications, 2023). In October 2024, Brainlab acquired the surgical robotics assets of German startup FibroTX, signaling intent to move into partial-knee and spinal robotics (per MedTech Dive, October 2024). Brainlab's structural differentiator is its founder-owned, debt-free model at a scale where almost all peers have gone public or been acquired. Vilsmeier has consistently declined IPO overtures (per Reuters, 2018) and rounds of venture funding, funding all R&D and M&A internally from operating cash flow. The company holds over 1,800 patents, making it one of the most IP-dense private companies in European medtech.